Pseudomonas aeruginosa in the ICU: prevalence, resistance profile, and antimicrobial consumption

INTRODUCTION: Pseudomonas aeruginosa is one of the main pathogens causing infection in intensive care units (ICUs) and usually presents antimicrobial resistance. METHODS: Data were obtained from ICUs between 2010 and 2013. RESULTS: P. aeruginosa had a prevalence of 14.5% of which 48.7% were multidru...

Descripción completa

Detalles Bibliográficos
Autores principales: Ribeiro, Ághata Cardoso da Silva, Crozatti, Márcia Terezinha Lonardoni, da Silva, Adilson Aderito, Macedo, Rodrigo Spineli, Machado, Antonia Maria de Oliveira, Silva, Antonio Távora de Albuquerque
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Medicina Tropical - SBMT 2019
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083346/
https://www.ncbi.nlm.nih.gov/pubmed/31859938
http://dx.doi.org/10.1590/0037-8682-0498-2018
_version_ 1783508513341833216
author Ribeiro, Ághata Cardoso da Silva
Crozatti, Márcia Terezinha Lonardoni
da Silva, Adilson Aderito
Macedo, Rodrigo Spineli
Machado, Antonia Maria de Oliveira
Silva, Antonio Távora de Albuquerque
author_facet Ribeiro, Ághata Cardoso da Silva
Crozatti, Márcia Terezinha Lonardoni
da Silva, Adilson Aderito
Macedo, Rodrigo Spineli
Machado, Antonia Maria de Oliveira
Silva, Antonio Távora de Albuquerque
author_sort Ribeiro, Ághata Cardoso da Silva
collection PubMed
description INTRODUCTION: Pseudomonas aeruginosa is one of the main pathogens causing infection in intensive care units (ICUs) and usually presents antimicrobial resistance. METHODS: Data were obtained from ICUs between 2010 and 2013. RESULTS: P. aeruginosa had a prevalence of 14.5% of which 48.7% were multidrug resistant. We observed increasing resistance to carbapenems and polymyxin B and growing consumption of aminoglycosides, meropenem, ceftazidime, and polymyxin B. The regression impact between resistance and consumption was significant with respect to amikacin, imipenem, meropenem, and polymyxin B. CONCLUSIONS: Monitoring antimicrobial consumption and resistant microorganisms should be reinforced to combat antimicrobial- and multi-drug resistance.
format Online
Article
Text
id pubmed-7083346
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Sociedade Brasileira de Medicina Tropical - SBMT
record_format MEDLINE/PubMed
spelling pubmed-70833462020-03-25 Pseudomonas aeruginosa in the ICU: prevalence, resistance profile, and antimicrobial consumption Ribeiro, Ághata Cardoso da Silva Crozatti, Márcia Terezinha Lonardoni da Silva, Adilson Aderito Macedo, Rodrigo Spineli Machado, Antonia Maria de Oliveira Silva, Antonio Távora de Albuquerque Rev Soc Bras Med Trop Short Communication INTRODUCTION: Pseudomonas aeruginosa is one of the main pathogens causing infection in intensive care units (ICUs) and usually presents antimicrobial resistance. METHODS: Data were obtained from ICUs between 2010 and 2013. RESULTS: P. aeruginosa had a prevalence of 14.5% of which 48.7% were multidrug resistant. We observed increasing resistance to carbapenems and polymyxin B and growing consumption of aminoglycosides, meropenem, ceftazidime, and polymyxin B. The regression impact between resistance and consumption was significant with respect to amikacin, imipenem, meropenem, and polymyxin B. CONCLUSIONS: Monitoring antimicrobial consumption and resistant microorganisms should be reinforced to combat antimicrobial- and multi-drug resistance. Sociedade Brasileira de Medicina Tropical - SBMT 2019-12-20 /pmc/articles/PMC7083346/ /pubmed/31859938 http://dx.doi.org/10.1590/0037-8682-0498-2018 Text en https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License
spellingShingle Short Communication
Ribeiro, Ághata Cardoso da Silva
Crozatti, Márcia Terezinha Lonardoni
da Silva, Adilson Aderito
Macedo, Rodrigo Spineli
Machado, Antonia Maria de Oliveira
Silva, Antonio Távora de Albuquerque
Pseudomonas aeruginosa in the ICU: prevalence, resistance profile, and antimicrobial consumption
title Pseudomonas aeruginosa in the ICU: prevalence, resistance profile, and antimicrobial consumption
title_full Pseudomonas aeruginosa in the ICU: prevalence, resistance profile, and antimicrobial consumption
title_fullStr Pseudomonas aeruginosa in the ICU: prevalence, resistance profile, and antimicrobial consumption
title_full_unstemmed Pseudomonas aeruginosa in the ICU: prevalence, resistance profile, and antimicrobial consumption
title_short Pseudomonas aeruginosa in the ICU: prevalence, resistance profile, and antimicrobial consumption
title_sort pseudomonas aeruginosa in the icu: prevalence, resistance profile, and antimicrobial consumption
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083346/
https://www.ncbi.nlm.nih.gov/pubmed/31859938
http://dx.doi.org/10.1590/0037-8682-0498-2018
work_keys_str_mv AT ribeiroaghatacardosodasilva pseudomonasaeruginosaintheicuprevalenceresistanceprofileandantimicrobialconsumption
AT crozattimarciaterezinhalonardoni pseudomonasaeruginosaintheicuprevalenceresistanceprofileandantimicrobialconsumption
AT dasilvaadilsonaderito pseudomonasaeruginosaintheicuprevalenceresistanceprofileandantimicrobialconsumption
AT macedorodrigospineli pseudomonasaeruginosaintheicuprevalenceresistanceprofileandantimicrobialconsumption
AT machadoantoniamariadeoliveira pseudomonasaeruginosaintheicuprevalenceresistanceprofileandantimicrobialconsumption
AT silvaantoniotavoradealbuquerque pseudomonasaeruginosaintheicuprevalenceresistanceprofileandantimicrobialconsumption

Ejemplares similares